Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

preCARDIA announced that its catheter-based system for acutely decompensated heart failure has received the FDA’s breakthrough device designation.

Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.

Experts agree that cardiology programs can help address the specialty's diversity problem—but what steps can be taken to make a real difference?  

The approval was based on data from two phase III randomized, treat-to-target studies. 

CMS has announced the formation of the Office of the Burden Reduction and Health Informatics, an organized effort to reduce regulatory and administrative burden and part of the agency’s Patients over Paperwork initiative.